Covaxin Gets Emergency Use Approval For Children Aged 2-18: Reports
Covaxin for children in India gets nod from top body in a much-awaited development in the country’s vaccination drive.
Covaxin for children in India gets nod from top body in a much-awaited development in the country’s vaccination drive.
“Totally agree. This is nothing short of disgusting and I’m wondering what kind of politics has brought this on. The @WHO must intervene immediately.”
A Bihar woman given two doses of COVID-19 vaccine under five minutes by mistake is under observation and reported to be well.
In March 2021, states and Union Territories were instructed to increase the gap of Covishield from 28 days to six-to-eight weeks “for better results”.
Kejriwal urges COVID-19 vaccine for below 18 years, further says manufacturers should consider reviewing prices at which vaccines will be sold to states.
US National Security Advisor Jake Sullivan confirmed that the US will send raw materials for Covishield to India to scale up the vaccine production.
“The study, though preliminary, does show that vaccination with Covishield offers protection against the double mutant variant. So people should go ahead and get vaccinated quickly,” said Mishra.
A look at the COVID-19 vaccines in India side-by-side and how they are different from each other.
Sputnik V vaccine against COVID-19 which is developed by Russia has now been approved and cleared for emergency use in India.
Time interval between the two doses of Covishield has been increased to 8 weeks. Here are the details.